Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23969788 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: Primary Peritoneal Cavity Cancer;   Stage III Ovarian Epithelial Cancer;   Stage IV Ovarian Epithelial Cancer
Interventions: Drug: ABI-007/carboplatin/trastuzumab;   Drug: gemcitabine hydrochloride;   Drug: 17-N-allylamino-17-demethoxygeldanamycin/paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: liposomal topotecan hydrochloride;   Procedure: conventional surgery

Indicates status has not been verified in more than two years